vs

Side-by-side financial comparison of CORE MOLDING TECHNOLOGIES INC (CMT) and Cryoport, Inc. (CYRX). Click either name above to swap in a different company.

CORE MOLDING TECHNOLOGIES INC is the larger business by last-quarter revenue ($74.7M vs $45.5M, roughly 1.6× Cryoport, Inc.). On growth, CORE MOLDING TECHNOLOGIES INC posted the faster year-over-year revenue change (19.5% vs 9.6%). CORE MOLDING TECHNOLOGIES INC produced more free cash flow last quarter ($-2.9M vs $-4.5M). Over the past eight quarters, Cryoport, Inc.'s revenue compounded faster (10.4% CAGR vs -2.2%).

Core Molding Technologies, Inc. was founded in 1988 and now based in Columbus, Ohio. The company manufactures sheet molding compounds (SMC), and molds fiberglass reinforced plastics. It occupies over 1,000,000 square feet of manufacturing space and its main subsidiaries are in Matamoros, Mexico, Gaffney, South Carolina, and Cincinnati, Ohio. In 2011, Core Molding Technologies formed Core Specialty Composites, LLC.

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

CMT vs CYRX — Head-to-Head

Bigger by revenue
CMT
CMT
1.6× larger
CMT
$74.7M
$45.5M
CYRX
Growing faster (revenue YoY)
CMT
CMT
+9.8% gap
CMT
19.5%
9.6%
CYRX
More free cash flow
CMT
CMT
$1.6M more FCF
CMT
$-2.9M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
CYRX
CYRX
Annualised
CYRX
10.4%
-2.2%
CMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMT
CMT
CYRX
CYRX
Revenue
$74.7M
$45.5M
Net Profit
$-8.0M
Gross Margin
15.2%
47.8%
Operating Margin
4.8%
-17.0%
Net Margin
-17.5%
Revenue YoY
19.5%
9.6%
Net Profit YoY
57.4%
EPS (diluted)
$0.35
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMT
CMT
CYRX
CYRX
Q4 25
$74.7M
$45.5M
Q3 25
$58.4M
$44.2M
Q2 25
$79.2M
$45.5M
Q1 25
$61.4M
$41.0M
Q4 24
$62.5M
$41.5M
Q3 24
$73.0M
$38.3M
Q2 24
$88.7M
$39.7M
Q1 24
$78.1M
$37.3M
Net Profit
CMT
CMT
CYRX
CYRX
Q4 25
$-8.0M
Q3 25
$1.9M
$-6.9M
Q2 25
$4.1M
$105.2M
Q1 25
$2.2M
$-12.0M
Q4 24
$-18.7M
Q3 24
$3.2M
$805.0K
Q2 24
$6.4M
$-78.0M
Q1 24
$3.8M
$-18.9M
Gross Margin
CMT
CMT
CYRX
CYRX
Q4 25
15.2%
47.8%
Q3 25
17.4%
48.2%
Q2 25
18.1%
47.0%
Q1 25
19.2%
45.4%
Q4 24
15.8%
47.0%
Q3 24
16.9%
45.5%
Q2 24
20.0%
44.5%
Q1 24
17.0%
40.4%
Operating Margin
CMT
CMT
CYRX
CYRX
Q4 25
4.8%
-17.0%
Q3 25
4.4%
-22.5%
Q2 25
6.6%
-21.2%
Q1 25
4.6%
-23.1%
Q4 24
1.4%
-30.7%
Q3 24
4.9%
-34.9%
Q2 24
8.4%
-196.5%
Q1 24
6.1%
-46.9%
Net Margin
CMT
CMT
CYRX
CYRX
Q4 25
-17.5%
Q3 25
3.2%
-15.7%
Q2 25
5.1%
231.4%
Q1 25
3.6%
-29.2%
Q4 24
-45.1%
Q3 24
4.3%
2.1%
Q2 24
7.2%
-196.4%
Q1 24
4.8%
-50.7%
EPS (diluted)
CMT
CMT
CYRX
CYRX
Q4 25
$0.35
$-0.19
Q3 25
$0.22
$-0.18
Q2 25
$0.47
$2.05
Q1 25
$0.25
$-0.28
Q4 24
$-0.01
$-0.42
Q3 24
$0.36
$-0.02
Q2 24
$0.73
$-1.62
Q1 24
$0.43
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMT
CMT
CYRX
CYRX
Cash + ST InvestmentsLiquidity on hand
$38.1M
$411.2M
Total DebtLower is stronger
$17.6M
Stockholders' EquityBook value
$158.2M
$502.6M
Total Assets
$228.1M
$765.0M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMT
CMT
CYRX
CYRX
Q4 25
$38.1M
$411.2M
Q3 25
$42.4M
$421.3M
Q2 25
$43.2M
$426.0M
Q1 25
$44.5M
$244.0M
Q4 24
$41.8M
$250.6M
Q3 24
$42.3M
$259.4M
Q2 24
$37.8M
$414.9M
Q1 24
$26.6M
$438.2M
Total Debt
CMT
CMT
CYRX
CYRX
Q4 25
$17.6M
Q3 25
$18.2M
Q2 25
$18.8M
Q1 25
$19.2M
Q4 24
$19.7M
Q3 24
$20.2M
Q2 24
$20.6M
Q1 24
$21.1M
Stockholders' Equity
CMT
CMT
CYRX
CYRX
Q4 25
$158.2M
$502.6M
Q3 25
$155.4M
$513.3M
Q2 25
$153.5M
$519.1M
Q1 25
$149.9M
$398.8M
Q4 24
$147.4M
$401.9M
Q3 24
$147.8M
$418.6M
Q2 24
$147.5M
$400.1M
Q1 24
$142.8M
$472.2M
Total Assets
CMT
CMT
CYRX
CYRX
Q4 25
$228.1M
$765.0M
Q3 25
$219.7M
$774.3M
Q2 25
$219.9M
$773.9M
Q1 25
$223.6M
$699.8M
Q4 24
$209.6M
$703.5M
Q3 24
$220.7M
$701.8M
Q2 24
$225.7M
$852.3M
Q1 24
$212.3M
$942.8M
Debt / Equity
CMT
CMT
CYRX
CYRX
Q4 25
0.11×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.14×
Q2 24
0.14×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMT
CMT
CYRX
CYRX
Operating Cash FlowLast quarter
$5.0M
$919.0K
Free Cash FlowOCF − Capex
$-2.9M
$-4.5M
FCF MarginFCF / Revenue
-3.9%
-10.0%
Capex IntensityCapex / Revenue
10.7%
12.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.9M
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMT
CMT
CYRX
CYRX
Q4 25
$5.0M
$919.0K
Q3 25
$4.6M
$2.2M
Q2 25
$3.5M
$-7.3M
Q1 25
$6.1M
$-4.3M
Q4 24
$5.0M
$-5.5M
Q3 24
$9.2M
$447.0K
Q2 24
$15.9M
$-8.0M
Q1 24
$5.1M
$-3.3M
Free Cash Flow
CMT
CMT
CYRX
CYRX
Q4 25
$-2.9M
$-4.5M
Q3 25
$-346.0K
$-1.3M
Q2 25
$880.0K
$-11.7M
Q1 25
$4.3M
$-7.5M
Q4 24
$509.0K
$-10.7M
Q3 24
$7.0M
$-3.8M
Q2 24
$13.0M
$-11.8M
Q1 24
$3.2M
$-7.3M
FCF Margin
CMT
CMT
CYRX
CYRX
Q4 25
-3.9%
-10.0%
Q3 25
-0.6%
-2.9%
Q2 25
1.1%
-25.7%
Q1 25
7.0%
-18.3%
Q4 24
0.8%
-25.8%
Q3 24
9.6%
-9.9%
Q2 24
14.6%
-29.8%
Q1 24
4.1%
-19.5%
Capex Intensity
CMT
CMT
CYRX
CYRX
Q4 25
10.7%
12.0%
Q3 25
8.4%
7.8%
Q2 25
3.3%
9.6%
Q1 25
2.9%
7.7%
Q4 24
7.2%
12.6%
Q3 24
3.1%
11.1%
Q2 24
3.3%
9.5%
Q1 24
2.4%
10.7%
Cash Conversion
CMT
CMT
CYRX
CYRX
Q4 25
Q3 25
2.44×
Q2 25
0.86×
-0.07×
Q1 25
2.79×
Q4 24
Q3 24
2.92×
0.56×
Q2 24
2.47×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons